Triple therapy versus dual-antiplatelet therapy for dolichoectatic vertebrobasilar fusiform aneurysms treated with flow diverters.
Adnan H SiddiquiAndre MonteiroRicardo A HanelPeter T KanAlina MohantyGustavo M CortezMargarita RabinovichCharles C MatoukNanthiya SujijantaratCharles RomeroJeremy StoneKoji EbersoleLane FrySabareesh K NatarajanBrittany Owusu-AdjeiSantiago Ortega GutierrezJuan Vivanco-SuarezAjay K WakhlooElad I LevyPublished in: Journal of neurointerventional surgery (2022)
Patients with DVBFAs treated with FD in the TT group had fewer ischemic strokes, less symptom progression, and overall better outcomes at last follow-up than similar patients in the DAPT group.
Keyphrases
- antiplatelet therapy
- newly diagnosed
- acute coronary syndrome
- percutaneous coronary intervention
- end stage renal disease
- ejection fraction
- chronic kidney disease
- prognostic factors
- type diabetes
- patient reported outcomes
- coronary artery disease
- adipose tissue
- metabolic syndrome
- atrial fibrillation
- skeletal muscle
- cerebral ischemia
- subarachnoid hemorrhage